Features of the Clinical Course, Complications and Lethality of Chronic Diffused Liver Diseases After Carrying Out Covid -19.

dc.contributor.author	Sh. T. O`roqov
dc.date.accessioned	2026-01-01T21:16:29Z
dc.date.issued	2023-06-10
dc.description.abstract	This article discusses the features of the clinical course of patients with chronic diffuse liver diseases (CDLD) against the background of COVID-19. The meta-analysis included 34 patients from the period 2022-2023, who were selected into two groups of cirrhosis and chronic hepatitis of the liver. Laboratory, clinical, instrumental data of patients were analyzed
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/erb/article/view/4419
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/67178
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/erb/article/view/4419/3756
dc.source	Eurasian Research Bulletin ; Vol. 21 (2023): ERB; 85-86
dc.source	2795-7675
dc.subject	CDLD
dc.subject	ascites
dc.subject	encephalopathy
dc.title	Features of the Clinical Course, Complications and Lethality of Chronic Diffused Liver Diseases After Carrying Out Covid -19.
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: oroqov_2023_features_of_the_clinical_course_complica.pdf
item.page.filesection.size: 160.19 KB
item.page.filesection.format: Adobe Portable Document Format